Unseen Adversaries: The Critical Impact of Airborne Pathogens on Healthcare Safety and Economics
A LifeAire Systems white paper examining the critical impact of airborne pathogens on healthcare safety and economics. The paper reviews the $28.4 billion annual cost of healthcare-associated infections in the United States, the limitations of HEPA filtration as a capture-only strategy that does not neutralize pathogens or eliminate VOCs, and the paradigm shift represented by ASHRAE 241: Control of Infectious Aerosols — which establishes new standards for single-pass pathogen inactivation that LifeAire’s technology meets and surpasses. The paper presents comparative environmental data showing 1,778 cfu/m3 viable biological pathogens and 1,372 ppb chemical contamination in HEPA-only clinical environments versus less than 1 cfu/m3 biological and less than 100 ppb chemical in HEPA plus LifeAire-purified environments. Includes study design details from the St. Luke’s Allentown 12-month hospital study, long-term care outcomes, and ASHRAE publication references. Published by LifeAire Systems, 2026.
